The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Vertex Pharmaceuticals Inc  (VRTX) Trade Now »     Rate VRTX  -  Discuss VRTX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
75.0%
Top:
100.0%
Rate VRTX:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

VRTX: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on VRTX ... Graphic_rating_buy VRTX
44%
 +42.02%
in 859 days

Jul 5:   Maybe, we're a little late on this one but there's probably still a distance to go given all the buy signals on the chart...

Find the chart and other analysis at http://stockcharts.com/def/servlet/Favorites.CServlet?obj=ID2...

By  tmm   (+0.65%  risk: aggressive)  07/05/07 Comment


Bullish on VRTX ... Graphic_rating_buy VRTX
N/A
 -3.29%
in 3 days
(closed on 05/24/07)

Analysis available here:

http://stockcharts.com/def/servlet/Favorites.CServlet?obj=ID2...

By  T MM   (+0.84%  risk: aggressive)  05/21/07 Comment


VRTX- A leadership biotech Graphic_rating_buy VRTX
Bull_flag_example
N/A
 +0.53%
in 3 days
(closed on 12/11/06)

In this morning at $42.80...   Made a morning low after a downswing..  This offers a lower-risk entry point into a strong daily/weekly pattern...    If it pushes up strongly from here, could breakout out of its 12-month base resistance at $44.75 and print a wide bar up to high $40's...  If it does not trade higher in the afternoon today --  will exit and look to re-enter...
By  Bull_flags   (+1.17%  risk: aggressive)  12/08/06 Comment




From the Blogosphere

Decoupled moves in Biotech indices highlight opportunities and challenges
52%

The chart below shows returns for the last 6 months of the two Biotech indices that I follow: BTK and NBI.

<>After a significant and equivalent downside move in March, both indices have turned positive with an explosive move since middle of July. I speculate that the March downside move was a response to concerns over Obama's health care proposal and its impact on Medicare. However, upon further examination, the adjustments in Medicare rebates would translate to no more than a double digit change in revenues. Moreover, the biotech story is in large a product story where launch of a new pr...
By  jmho   (-9.41%  risk: aggressive)  07/25/09 Comment


Vertex: Long Term Buy Opportunity

By: Jason Napodano, CFA

Vertex Pharmaceuticals, Inc. (VRTX) represents an attractive long-term opportunity based on the potential blockbuster sales of telaprevir and its newly established position as the market leader for new HCV treatment options with the closing of the ViroChem deal in March 2009. Also, VX-770 for cystic fibrosis also looks very interesting. The financial situation is also solid with an estimated $700 million in cash predicted to be on hand at the end of the year.
By  trackseekingalpha   (-13.69%  risk: aggressive)  06/02/09 Comment


Bookkeeping: Closing Short on Sequenom (SQNM)
Tradermark
34%
Uhhh... obviously in the $3s I think most of the downside is in, unless it goes to zero. Unfortunately as I stated last night I covered most of my short early this week, so these are the last 50 shares. Having a hedge at this point is useless.

I am not a speculator of the highest order, but of course if you have spare money to toss around you can buy on the long side. Per James Altucher Ridgeback Capital (a hedge fund) had 92% of their portfolio in Sequenom so you can say goodbye to that fund. And RA Capital (another fund) has 50% of their portfolio in the stock.

One interesting play is a...
By  Trader Mark   (-7.11%  risk: moderate)  04/30/09 Comment


Vertex Pharma (VRTX) - Testing support, looks short / Prueba de soporte, se ve corto
Tradinggoddess
 5 %


English-
VRTX- The stock is testing support (lateral and uptrend). Look for a break below the 26.30 level to enter shorts as this would signal a break in support. Price target of 24.45.


Español-
VRTX -La accion esta en prueba de soporte (lateral y tendencia alcista). Se busca ruptura por debajo de los 26.30 para entrar en cortos. Objetivo es de 24.45.
By  Trading Goddess   (-46.13%  risk: aggressive)  04/06/09 Comment


Earnings results and economic reports - Week 44.
Vld2czech
15%
Monday:
Economic New Home Sales (450K)
Earnings Arch Coal (ACI), Humana (HUM), FPL (FPL), Sohu (SOHU), Tidewater (TDW), Verizon (VZ), Atheros (ATHR), CF Ind (CF), Meritage (MTH), Vertex (VRTX), Zoran (ZRAN), Universal Health (UHS)

Tuesday:
Economic Consumer Confidence (52.0)
Earnings Boyd (BYD), BP (BP), Ceradyne (CRDN), KC Southern (KSU), Royal Carib (RCL), SAP (SAP), Schnitzer (SCHN), US Steel (X), Under Armour (UA), USG (USG), Valero (VLO), Whirlpool (WHR), Apollo (APOL), Centex (CTX), Cephalon (CEPH), Fiserv (FISV), GMarket (GMKT), Lan Air (LFL), McKesson (MCK), NetLogic (NETL), Walter (WLT)...
By  Vlada Kynsky   (-27.03%  risk: aggressive)  10/27/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.57% 370
2 Gerald Greene 18.14 +68.57% 207
3 stockmarketfunding.com 17.66 +25.68% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +77.15% 34


POPULAR STOCKS
Symbol Company Name Sentiment
IBM International Business Machines Corp
RIO Companhia Vale Do Rio Doce
ETFC E*Trade Financial Corp
PG The Procter & Gamble Company
GOOG Google Inc
RIMM Research in Motion Ltd

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on VRTX

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Vertex Pharmaceuticals Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch